What pain medications are appropriate for a patient with gastroparesis?

Pain Management in Gastroparesis: Avoid Opioids and Consider Neuromodulators

Opioid analgesics should NOT be used for pain management in gastroparesis patients, as they worsen gastric emptying, increase risk of narcotic bowel syndrome, and create potential for addiction 1. This is explicitly stated in the 2022 AGA expert review as Best Practice Advice #6.

First-Line Approach: Neuromodulators for Abdominal Pain

For gastroparesis-associated abdominal pain, neuromodulators are the recommended pharmacologic approach 1:

Tricyclic Antidepressants (TCAs)

• Amitriptyline or imipramine (tertiary amines): 25-100 mg/day

  • More potent for pain control but higher side effect profile (sedation)
  • Particularly beneficial when epigastric pain is prominent
  • Work via noradrenaline reuptake inhibition to control visceral pain 1

• Nortriptyline or desipramine (secondary amines): 25-75 mg/day

  • Better tolerated with fewer anticholinergic effects
  • Note: Nortriptyline showed no benefit in the NORIG trial for idiopathic gastroparesis, but hasn't been tested in diabetic gastroparesis 1

SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)

• Duloxetine: 60-120 mg/day
  • Blocks reuptake of both serotonin and norepinephrine
  • Proven effective for diabetic neuropathic pain in RCTs
  • Caution: May worsen nausea or constipation 1

Anticonvulsants for Neuropathic Pain Component

• Gabapentin: >1200 mg/day in divided doses

  • Evidence shows >50% pain reduction compared to placebo
  • Some concerns about selective outcome reporting in industry trials 1

• Pregabalin: 150-600 mg/day in divided doses

  • Pooled analysis from 7 RCTs showed significant pain reduction
  • Side effects: dizziness, somnolence, weight gain, peripheral edema 1

Alternative Agents

Mirtazapine

• Dose: 7.5-30 mg/day
• Tetracyclic antidepressant with noradrenergic and serotonergic activity
• Improved refractory nausea/vomiting in gastroparesis cohort
• Also addresses early satiation and weight loss 1

Non-Opioid Analgesics for Acute Pain

Acetaminophen/NSAIDs

• Can be added for more severe acute cramping pain 2
• Use cautiously and short-term given GI side effect profile of NSAIDs

Antispasmodics

• Hyoscine-N-butyl bromide or mebeverine as primary treatment for GI cramping pain
• If ineffective, switch to different mechanism of action 2

Critical Pitfalls to Avoid

1. Never prescribe opioids - They delay gastric emptying further, risk narcotic bowel syndrome, and create addiction potential 1

2. Review current medications - Eliminate any medications that delay gastric motility before adding pain medications 3

3. Identify predominant symptom - If pain is the dominant symptom, consider whether this is truly gastroparesis or an alternative diagnosis 3, 1

4. Start low, go slow with neuromodulators - Begin at lower doses and titrate up over 1-4 weeks to improve tolerability 3

5. Assess efficacy at 4-8 weeks before deciding to continue or adjust treatment 3

Specialized Interventions for Refractory Pain

If pharmacologic management fails:

• Celiac plexus block with local anesthesia and steroid injection has shown success in case reports for severe refractory gastroparesis pain 4
• Intravenous phentolamine (0.5 mg/kg over 60 minutes) for acute pain crisis, followed by oral clonidine 0.1 mg twice daily for maintenance 5

Algorithm Summary

1. Exclude opioids completely
2. Start TCA (amitriptyline 25 mg at bedtime) or SNRI (duloxetine 60 mg daily)
3. Add anticonvulsant (gabapentin or pregabalin) if inadequate response after 4-8 weeks
4. Consider mirtazapine if nausea/vomiting and weight loss are prominent alongside pain
5. Reserve interventional approaches (celiac plexus block) for truly refractory cases

The 2025 AGA guideline emphasizes that pain management in gastroparesis requires a symptom-targeted approach rather than simply treating delayed emptying 3.